ArticleCancers2026

Dynamic Plasma KRAS ctDNA Profiling Identifies Treatment Response and Nascent Resistance in Metastatic Non-Small-Cell Lung Cancer: A Pilot Study.

Valentina Buzzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.